Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior government funding operating-status notice (and Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:22.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    New site-wide notice about government funding and NIH Clinical Center status appears, and the page revision is updated to v3.4.1; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:41:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary toggle was added and a revision indicator (Revision: v3.4.0) appears on the page. QC-related labels and policy wording were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').
    Difference
    0.1%
    Check dated 2026-01-28T06:19:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This update appears to be a metadata/version tag and does not modify core study content.
    Difference
    0.0%
    Check dated 2026-01-14T02:32:36.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing multiple U.S. states as study sites and updated the revision to v3.3.3; the prior v3.3.2 location listings and the HHS disclosure item were removed.
    Difference
    2%
    Check dated 2025-12-23T17:21:19.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.